Like most organisations around the world, Starpharma continues to closely monitor the COVID-19 pandemic and its impact.

The health and safety of our people, trial patients and VivaGel® customers is paramount. From the outset Starpharma implemented a comprehensive range of measures to protect the health and safety of our workforce while continuing to deliver and develop medicines for patients in need.

Starpharma has taken a variety of steps to limit the spread of COVID-19 including stringent hygiene protocols and employee education to ensure our staff can continue in their roles in a safe and secure way, instructing staff to work from home where possible, minimise onsite visitation and procedures when required, and daily cleaning/disinfecting on the premises to minimise business disruption.

We will continue to update our policies based on medical advice and changes to Government directives and encourage staff to do what they can to prevent the spread.

Our management team is monitoring and reviewing the situation daily, and we will continue to update our measures as appropriate.